Outcome of dogs with low- and high-grade mast cell tumors treated with electrochemotherapy
Journal of Veterinary Internal Medicine · 21.01.2026 · 40 (1)
DOI: 10.1093/jvimsj/aalaf081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, online erschienen am 06.02.2026. Verfasst von Javier Ojeda und 4 weiteren Autor:innen. Beteiligte Einrichtung: Escuela de Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago 8370251, Chile. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Mast cell tumors (MCTs) in dogs pose therapeutic challenges that vary with histopathological grade. Hypothesis/Objectives Electrochemotherapy (ECT) alone would result in a clinically meaningful response in nonmetastatic cutaneous MCTs, with efficacy varying by tumor grade. Animals Twenty-nine client-owned dogs with 39 nonmetastatic cutaneous MCTs were treated at a veterinary oncology referral center. Tumors were classified as low grade (n = 27) or high grade (n = 12) according to the Kiupel system.
Methods
This retrospective cohort study evaluated outcomes after ECT as the sole treatment. The primary outcomes were complete remission (CR) rate, median survival time, and disease-free interval. Electrochemotherapy was administered using standardized protocols, with follow-up ranging from 30 to 1600 days.
Results
Overall complete remission rate was 79% (95% CI, 63.5-90.7). Complete remission was achieved in 100% of low-grade tumors (27/27; 95% CI, 87.2-100) versus 45% of high-grade tumors (5/12; 95% CI, 18.1-75.4). Median survival time was 1198 days (range 188-1920 days) for low-grade MCTs and 210 days (range 45-765 days) for high-grade MCTs (P = .001). Median disease-free interval was 1080 days (range 188-1920 days) and 455 days (range 45-865 days) for low- and high-grade tumors, respectively. Median tumor volume was 4.8 cm3; low-grade tumors were generally smaller. The average number of treatments was 1.1 for low-grade and 1.6 for high-grade tumors. Conclusions and clinical importance ECT is an effective local treatment for low-grade MCTs, offering outcomes comparable to surgical management. For high-grade tumors, its benefit is limited to small-volume disease where surgery is not feasible.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Escuela de Medicina Veterinaria, Facultad de Ciencias de la Vida, Universidad Andres Bello, Santiago 8370251, Chile.
- Institute of Clinical Veterinary Sciences, Faculty of Veterinary Sciences, Universidad Austral de Chile, Valdivia 5090000, Chile.
- Departamento de Ciencias Veterinarias y Salud Pública, Facultad de Recursos Naturales, Universidad Católica de Temuco, Temuco, Chile.
ORCID-Profile: Javier Ojeda
Zitieren
APA
Ojeda, J., Caixeta, M. L., Mieres, M., Sandoval, P., & Ortloff, A. (2026). Outcome of dogs with low- and high-grade mast cell tumors treated with electrochemotherapy. Journal of Veterinary Internal Medicine, 40(1). https://doi.org/10.1093/jvimsj/aalaf081
Vancouver
Ojeda J, Caixeta ML, Mieres M, Sandoval P, Ortloff A. Outcome of dogs with low- and high-grade mast cell tumors treated with electrochemotherapy. Journal of Veterinary Internal Medicine. 2026;40(1). doi:10.1093/jvimsj/aalaf081
BibTeX
@article{Ojeda2026,
author = {Ojeda, Javier and Caixeta, Maria Laura and Mieres, Marcelo and Sandoval, Paulina and Ortloff, Alexander},
title = {Outcome of dogs with low- and high-grade mast cell tumors treated with electrochemotherapy},
journal = {Journal of Veterinary Internal Medicine},
year = {2026},
volume = {40},
number = {1},
doi = {10.1093/jvimsj/aalaf081}
}
EUVIMED